SwePub
Sök i LIBRIS databas

  Utökad sökning

WFRF:(Nankervis H.)
 

Sökning: WFRF:(Nankervis H.) > Evaluation of the m...

LIBRIS Formathandbok  (Information om MARC21)
FältnamnIndikatorerMetadata
00004517naa a2200481 4500
001oai:lup.lub.lu.se:1535e452-a62c-4e94-964f-34937f1f9f05
003SwePub
008161116s2017 | |||||||||||000 ||eng|
0247 a https://lup.lub.lu.se/record/1535e452-a62c-4e94-964f-34937f1f9f052 URI
0247 a https://doi.org/10.1111/all.129592 DOI
040 a (SwePub)lu
041 a engb eng
042 9 SwePub
072 7a art2 swepub-publicationtype
072 7a ref2 swepub-contenttype
1001 a Gerbens, L. A Au Academic Medical Center of University of Amsterdam (AMC)4 aut
2451 0a Evaluation of the measurement properties of symptom measurement instruments for atopic eczema : A systematic review
264 c 2016-07-13
264 1b Wiley,c 2017
520 a Background: Symptoms have been identified as a core outcome domain for atopic eczema (AE) trials. Various instruments exist to measure symptoms in AE, but they vary in quality and there is a lack of standardization between clinical trials. Our objective was to systematically evaluate the quality of the evidence on the measurement properties of AE symptom instruments, thereby informing consensus discussions within the Harmonising Outcome Measures for Eczema (HOME) initiative regarding the most appropriate instruments for the core outcome domain symptoms. Methods: Using the COnsensus-based Standards for the selection of health Measurement INstruments (COSMIN) checklist and predefined criteria for good measurement properties on identified development and validation studies of AE symptom instruments, a best evidence synthesis was performed to draw an overall conclusion on quality of the instruments and to provide recommendations. Results: Eighteen instruments were identified and evaluated. When the quality and results of the studies were considered, only five of these instruments had sufficient validation data to consider them for the core outcome set for the core outcome domain symptoms. These were the paediatric Itch Severity Scale (ISS), Patient-Oriented Eczema Measure (POEM), Patient-Oriented SCOring Atopic Dermatitis (PO-SCORAD), Self-Administered Eczema Area and Severity Index (SA-EASI) and adapted SA-EASI. Conclusions: ISS (paediatric version), POEM, PO-SCORAD, SA-EASI and adapted SA-EASI are currently the most appropriate instruments and therefore have the potential to be recommended as core symptom instrument in future clinical trials. These findings will be utilized for the development of a core outcome set for AE.
650 7a MEDICIN OCH HÄLSOVETENSKAPx Klinisk medicinx Dermatologi och venereologi0 (SwePub)302042 hsv//swe
650 7a MEDICAL AND HEALTH SCIENCESx Clinical Medicinex Dermatology and Venereal Diseases0 (SwePub)302042 hsv//eng
653 a Atopic eczema
653 a Core outcome set
653 a Harmonising Outcome Measures for Eczema (HOME) initiative
653 a Measurement properties
653 a Symptoms
7001 a Prinsen, C. A Cu Amsterdam UMC - Vrije Universiteit Amsterdam4 aut
7001 a Chalmers, J. R.u University of Nottingham4 aut
7001 a Drucker, A. M.u Brown University4 aut
7001 a von Kobyletzki, L. B.u Lund University,Lunds universitet,Yrkes- och miljödermatologi,Forskargrupper vid Lunds universitet,Occupational and Environmental Dermatology,Lund University Research Groups4 aut0 (Swepub:lu)la7747vo
7001 a Limpens, J.u Academic Medical Center of University of Amsterdam (AMC)4 aut
7001 a Nankervis, H.u University of Nottingham4 aut
7001 a Svensson, Åkeu Lund University,Lunds universitet,Yrkes- och miljödermatologi,Forskargrupper vid Lunds universitet,Occupational and Environmental Dermatology,Lund University Research Groups4 aut0 (Swepub:lu)derm-asv
7001 a Terwee, C. B.u Amsterdam UMC - Vrije Universiteit Amsterdam4 aut
7001 a Zhang, J.u Peking University4 aut
7001 a Apfelbacher, C. J.u University of Regensburg4 aut
7001 a Spuls, P. I.u Academic Medical Center of University of Amsterdam (AMC)4 aut
7102 a Academic Medical Center of University of Amsterdam (AMC)b Amsterdam UMC - Vrije Universiteit Amsterdam4 org
7730 t Allergy: European Journal of Allergy and Clinical Immunologyd : Wileyg 72:1, s. 146-163q 72:1<146-163x 0105-4538
8564 u http://dx.doi.org/10.1111/all.12959y FULLTEXT
8564 8u https://lup.lub.lu.se/record/1535e452-a62c-4e94-964f-34937f1f9f05
8564 8u https://doi.org/10.1111/all.12959

Hitta via bibliotek

Till lärosätets databas

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy